Male patients with the ACE2 rs2074192 (T) and rs2106809 (A) variants had a lower risk of developing obesity and hypertriglyceridemia (all P < 0.05, after adjusting for age, smoking and drinking status, respectively, Fig. 3). Here, ACE2 is linked to hypertriglyceridemia.